Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Recruiting · NCT07063537 · Interventional (participants receive a specific treatment) · Lead sponsor: Nova Scotia Health Authority
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Who can take part
Inclusion criteria
- \>18 years of age
- diagnosis of primary open-angle glaucoma
- ability to perform visual field testing
- capacity to provide informed consent to research protocol
Exclusion criteria
- diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy
- previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
- significant media opacity
- pregnancy
- seizure disorder
- cardiac pacemaker/other implantable device
- severe vertigo/balance disorder
Where it is running
1 location listed.
- Eadie Technologies Inc - Halifax, Nova Scotia, Canada